CA3144953C - METHODS FOR PREPARING TOLL-TYPE RECEIVER MODULATOR COMPONENTS - Google Patents
METHODS FOR PREPARING TOLL-TYPE RECEIVER MODULATOR COMPONENTSInfo
- Publication number
- CA3144953C CA3144953C CA3144953A CA3144953A CA3144953C CA 3144953 C CA3144953 C CA 3144953C CA 3144953 A CA3144953 A CA 3144953A CA 3144953 A CA3144953 A CA 3144953A CA 3144953 C CA3144953 C CA 3144953C
- Authority
- CA
- Canada
- Prior art keywords
- formula
- salt
- compound
- solvent
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA3248411A CA3248411A1 (en) | 2019-06-28 | 2020-06-25 | METHODS FOR PREPARING TOLL-TYPE RECEIVER MODULATOR COMPOUNDS |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962868662P | 2019-06-28 | 2019-06-28 | |
| US62/868,662 | 2019-06-28 | ||
| PCT/US2020/039501 WO2020264081A1 (en) | 2019-06-28 | 2020-06-25 | Processes for preparing toll-like receptor modulator compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3248411A Division CA3248411A1 (en) | 2019-06-28 | 2020-06-25 | METHODS FOR PREPARING TOLL-TYPE RECEIVER MODULATOR COMPOUNDS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA3144953A1 CA3144953A1 (en) | 2020-12-30 |
| CA3144953C true CA3144953C (en) | 2025-11-18 |
Family
ID=71608089
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3144953A Active CA3144953C (en) | 2019-06-28 | 2020-06-25 | METHODS FOR PREPARING TOLL-TYPE RECEIVER MODULATOR COMPONENTS |
| CA3248411A Pending CA3248411A1 (en) | 2019-06-28 | 2020-06-25 | METHODS FOR PREPARING TOLL-TYPE RECEIVER MODULATOR COMPOUNDS |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3248411A Pending CA3248411A1 (en) | 2019-06-28 | 2020-06-25 | METHODS FOR PREPARING TOLL-TYPE RECEIVER MODULATOR COMPOUNDS |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11286257B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3990455A1 (cg-RX-API-DMAC10.html) |
| JP (2) | JP7246526B2 (cg-RX-API-DMAC10.html) |
| KR (2) | KR102670017B1 (cg-RX-API-DMAC10.html) |
| CN (2) | CN114269744B (cg-RX-API-DMAC10.html) |
| AU (2) | AU2020304069C1 (cg-RX-API-DMAC10.html) |
| CA (2) | CA3144953C (cg-RX-API-DMAC10.html) |
| TW (1) | TWI879779B (cg-RX-API-DMAC10.html) |
| WO (1) | WO2020264081A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008009078A2 (en) | 2006-07-20 | 2008-01-24 | Gilead Sciences, Inc. | 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections |
| SG11201606876RA (en) | 2015-03-04 | 2016-10-28 | Gilead Sciences Inc | Toll like receptor modulator compounds |
| SI3507276T1 (sl) | 2016-09-02 | 2022-01-31 | Gilead Sciences, Inc. | Spojine modulatorja toličnih receptorjev |
| TW202210480A (zh) | 2019-04-17 | 2022-03-16 | 美商基利科學股份有限公司 | 類鐸受體調節劑之固體形式 |
| TWI751517B (zh) | 2019-04-17 | 2022-01-01 | 美商基利科學股份有限公司 | 類鐸受體調節劑之固體形式 |
| TWI879779B (zh) | 2019-06-28 | 2025-04-11 | 美商基利科學股份有限公司 | 類鐸受體調節劑化合物的製備方法 |
| CN114031615B (zh) * | 2021-11-19 | 2023-09-19 | 中国科学院上海有机化学研究所 | 羟基取代的吡啶噁唑啉配体及其在烯烃的氢卤化反应中的应用 |
| CN119095829A (zh) * | 2022-05-04 | 2024-12-06 | 贺利氏贵金属有限两合公司 | 用于制备4-[5-[双(2-氯乙基)氨基]-1-甲基-1H-苯并[d]咪唑-2-基]丁酸烷基酯和甲酰化衍生物的方法 |
Family Cites Families (186)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2512572A (en) | 1950-06-20 | Substituted pteridines and method | ||
| DE267495C (de) | 1913-09-07 | 1913-11-20 | Max Schreiber | Sicherheitsschloss für schmucksachen |
| CH231852A (de) | 1940-08-09 | 1944-04-15 | Ig Farbenindustrie Ag | Verfahren zur Herstellung eines Kondensationsproduktes. |
| US2581889A (en) | 1948-07-07 | 1952-01-08 | Burroughs Wellcome Co | Method of preparing pyrimidopyrazines |
| US2665275A (en) | 1948-12-22 | 1954-01-05 | Allen & Hanburys Ltd | 2, 4-diamino-7, 8-disubstituted pteridines |
| GB677342A (en) | 1949-08-19 | 1952-08-13 | Ici Ltd | New pyrimidine derivatives and their use in the manufacture of pteridin derivatives |
| US2667486A (en) | 1951-05-24 | 1954-01-26 | Research Corp | 2,4-diamino pteridine and derivatives |
| GB763044A (en) | 1952-04-18 | 1956-12-05 | Ici Ltd | Pteridin derivatives |
| GB785353A (en) | 1953-01-30 | 1957-10-30 | Merck & Co Inc | Substituted pteridine derivatives |
| US2740784A (en) | 1954-05-03 | 1956-04-03 | Merck & Co Inc | Process for preparing pteridines |
| US2940972A (en) | 1957-06-27 | 1960-06-14 | Thomae Gmbh Dr K | Tri-and tetra-substituted pteridine derivatives |
| US2939882A (en) | 1958-07-21 | 1960-06-07 | Shell Oil Co | Stabilized alpha, beta-unsaturated aldehydes |
| US3081230A (en) | 1960-09-08 | 1963-03-12 | Smith Kline French Lab | Diuretic and antihypertensive triaminoarylpteridines |
| US3071587A (en) | 1961-07-25 | 1963-01-01 | American Cyanamid Co | Cyanoethyl-pteridines |
| US3159628A (en) | 1962-05-28 | 1964-12-01 | Smith Kline French Lab | Pteridine-5-oxide derivatives |
| US3122546A (en) | 1962-12-03 | 1964-02-25 | American Home Prod | 4, 7-diamino-2-(substituted)-n-substituted-6-pteridinecarboxamides |
| US3162635A (en) | 1962-08-06 | 1964-12-22 | Searle & Co | 1, 2, 3, 4-tetrahydro-2, 4-pteridinediones and intermediates |
| NL131481C (cg-RX-API-DMAC10.html) | 1965-04-15 | |||
| DE1921308A1 (de) | 1969-04-25 | 1971-01-07 | Boehringer Sohn Ingelheim | Herzwirksame Zubereitungen |
| GB1301319A (cg-RX-API-DMAC10.html) | 1970-07-13 | 1972-12-29 | ||
| US3859287A (en) | 1971-05-05 | 1975-01-07 | Walter Wesley Parish | Thiopteridines and process for producing same |
| US3843791A (en) | 1973-01-11 | 1974-10-22 | Pfizer | Method of killing insects with quinazolinones and quinazoline-thiones |
| DE3023369A1 (de) | 1980-06-23 | 1982-01-14 | Boehringer Mannheim Gmbh, 6800 Mannheim | Aryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE3378634D1 (en) | 1982-09-20 | 1989-01-12 | Wellcome Found | Pharmaceutically active pteridine derivatives |
| DE3323932A1 (de) | 1983-07-02 | 1985-01-10 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue 2-piperazino-pteridine, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel |
| DE3445298A1 (de) | 1984-12-12 | 1986-06-12 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue pteridine, verfahren zu ihrer herstellung und deren verwendung als zwischenprodukte oder als arzneimittel |
| US5149705A (en) | 1987-03-13 | 1992-09-22 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a tetralin group and having retinoid like activity |
| IT1204612B (it) | 1987-05-14 | 1989-03-10 | Bioresearch Spa | Pteridine atte alla preparazione di composizioni farmaceutiche ad attivita' antiamnesica |
| IL88507A (en) | 1987-12-03 | 1993-02-21 | Smithkline Beckman Intercredit | 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them |
| DE3833393A1 (de) | 1988-10-01 | 1990-04-05 | Thomae Gmbh Dr K | Verwendung von pteridinen zur verhinderung der primaeren und sekundaeren resistenz bei der chemotherapie und diese verbindungen enthaltende arzneimittel |
| GB8910722D0 (en) | 1989-05-10 | 1989-06-28 | Smithkline Beckman Intercredit | Compounds |
| CA2015981A1 (en) | 1989-05-10 | 1990-11-10 | Thomas H. Brown | Compounds |
| GB8912336D0 (en) | 1989-05-30 | 1989-07-12 | Smithkline Beckman Intercredit | Compounds |
| DE4009941A1 (de) | 1990-03-28 | 1991-10-02 | Thomae Gmbh Dr K | Verwendung von pteridinen zur sensibilisierung resistenter plasmodien bei der malaria-chemotherapie und diese verbindungen enthaltende arzneimittel |
| PT100905A (pt) | 1991-09-30 | 1994-02-28 | Eisai Co Ltd | Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem |
| GB9125001D0 (en) | 1991-11-25 | 1992-01-22 | Ici Plc | Heterocyclic compounds |
| CA2128205C (en) | 1992-01-27 | 2004-03-30 | Hiroharu Matsuoka | Methotrexate derivatives |
| AU4535893A (en) | 1992-06-15 | 1994-01-04 | Regents Of The University Of California, The | Screening assay for the identification of immunosuppressive drugs |
| HU214331B (hu) | 1992-06-17 | 1998-03-02 | Gyógyszerkutató Intézet Kft. | Eljárás piperazin- és homopiperazinszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására |
| WO1994006431A1 (en) | 1992-09-22 | 1994-03-31 | Cell Therapeutics, Inc. | Novel epoxide-containing compounds |
| GB9221220D0 (en) | 1992-10-09 | 1992-11-25 | Sandoz Ag | Organic componds |
| US5473070A (en) | 1992-11-16 | 1995-12-05 | Cell Therapeutics, Inc. | Substituted long chain alcohol xanthine compounds |
| WO1994014065A1 (en) | 1992-12-14 | 1994-06-23 | Dana-Farber Cancer Institute, Inc. | Methods for identifying and using immunosuppressant compounds |
| IL108630A0 (en) | 1993-02-18 | 1994-05-30 | Fmc Corp | Insecticidal substituted 2,4-diaminoquinazolines |
| PH31122A (en) | 1993-03-31 | 1998-02-23 | Eisai Co Ltd | Nitrogen-containing fused-heterocycle compounds. |
| US5641783A (en) | 1993-11-12 | 1997-06-24 | Cell Therapeutics, Inc. | Substituted amino alcohol compounds |
| US5670506A (en) | 1993-04-05 | 1997-09-23 | Cell Therapeutics, Inc. | Halogen, isothiocyanate or azide substituted xanthines |
| US5281603A (en) | 1993-04-23 | 1994-01-25 | American Cyanamid Company | Angiotensin II receptor blocking 2,3,6 substituted quinazolinones |
| US5521190A (en) | 1993-05-27 | 1996-05-28 | Fmc Corporation | Insecticidal pterdines and 8-deazapteridines |
| US6043228A (en) | 1993-06-08 | 2000-03-28 | Cancer Research Campaign Technology Limited | O6 -substituted guanine derivatives, a process for their preparation and their use in treating tumor cells |
| WO1995013075A1 (en) | 1993-11-12 | 1995-05-18 | Cell Therapeutics, Inc. | Method for preventing tissue injury from hypoxia |
| JPH07138238A (ja) | 1993-11-16 | 1995-05-30 | Kanebo Ltd | 新規キナゾリン誘導体およびそれを有効成分とする抗腫瘍剤 |
| US5525711A (en) | 1994-05-18 | 1996-06-11 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Pteridine nucleotide analogs as fluorescent DNA probes |
| DE4418097A1 (de) | 1994-05-24 | 1995-11-30 | Cassella Ag | Verwendung von Tetrahydropteridin-Derivaten als Hemmstoffe der NO-Synthase |
| DE4418096A1 (de) | 1994-05-24 | 1995-11-30 | Cassella Ag | Verwendung von Pteridin-Derivaten als Hemmstoffe der NO-Synthase |
| US5929046A (en) | 1994-06-08 | 1999-07-27 | Cancer Research Campaign Technology Limited | Pyrimidine and purine derivatives and their use in treating tumour cells |
| US5607936A (en) | 1994-09-30 | 1997-03-04 | Merck & Co., Inc. | Substituted aryl piperazines as neurokinin antagonists |
| GB9424233D0 (en) | 1994-11-30 | 1995-01-18 | Zeneca Ltd | Quinazoline derivatives |
| US5843943A (en) | 1994-12-29 | 1998-12-01 | The Regents Of The University Of California | Compounds for inhibition of ceramide-mediated signal transduction |
| DE69527438T2 (de) | 1994-12-29 | 2003-03-06 | The Regents Of The University Of California, Oakland | Verbindungen zur hemmung der ceramid vermittelten signalübertragung |
| US6323201B1 (en) | 1994-12-29 | 2001-11-27 | The Regents Of The University Of California | Compounds for inhibition of ceramide-mediated signal transduction |
| DE19681160D2 (de) | 1995-12-22 | 1999-07-01 | Roche Diagnostics Gmbh | Polypeptide mit IL-16-Aktivität, Verfahren zu ihrer Herstellung und Verwendung |
| US5780462A (en) | 1995-12-27 | 1998-07-14 | American Home Products Corporation | Water soluble rapamycin esters |
| GB9603095D0 (en) | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
| US5663335A (en) | 1996-03-01 | 1997-09-02 | Pharmagenesis, Inc. | Immunosuppressive compounds and methods |
| AU2666997A (en) | 1996-04-15 | 1997-11-07 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | In vitro prognostic test for progressors and non-progressors after hiv infection |
| DE69733308D1 (de) | 1996-07-31 | 2005-06-23 | Cmic Co | Aktivsauerstoffaufnehmer enthaltende pterinderivate |
| DE69725721T3 (de) | 1996-08-30 | 2007-10-31 | Daiichi Asubio Pharma Co., Ltd. | Vorbeugende oder heilende mittel für krankheiten, die durch mangel an stickoxid-synthase (nos) ausgelöst sind |
| EP0837063A1 (en) | 1996-10-17 | 1998-04-22 | Pfizer Inc. | 4-Aminoquinazoline derivatives |
| US6203723B1 (en) | 1998-03-12 | 2001-03-20 | Ying Yen Hsu | Microencapsulated liquid crystal having multidomains induced by the polymer network and method |
| WO1999050264A1 (en) | 1998-03-30 | 1999-10-07 | Kyowa Hakko Kogyo Co., Ltd. | Quinazoline derivatives |
| DE69812070T2 (de) | 1998-04-24 | 2003-12-11 | K.U. Leuven Research & Development, Leuven | Immununterdrückende Effekte von 8 substituierten Xanthinderivaten |
| JP2000038350A (ja) | 1998-05-18 | 2000-02-08 | Yoshitomi Pharmaceut Ind Ltd | 糖尿病治療薬 |
| JP4315300B2 (ja) | 1998-08-10 | 2009-08-19 | 大日本住友製薬株式会社 | 新規なキナゾリン誘導体 |
| JP4342007B2 (ja) | 1998-08-10 | 2009-10-14 | 大日本住友製薬株式会社 | キナゾリン誘導体 |
| US5992713A (en) | 1998-10-23 | 1999-11-30 | Manabat; Gregorio S. | Clothes hanger with slidable side attachments |
| AU770551B2 (en) | 1998-12-28 | 2004-02-26 | 4-Aza Bioscience Nv | Immunosuppressive effects of pteridine derivatives |
| US7276506B2 (en) | 1998-12-28 | 2007-10-02 | 4 Aza Bioscience Nv | Immunosuppressive effects of pteridine derivatives |
| US6946465B2 (en) | 1999-02-02 | 2005-09-20 | 4 Aza Bioscience Nv | Immunosuppressive effects of pteridine derivatives |
| EP1187615A2 (en) | 1999-02-02 | 2002-03-20 | K.U. Leuven Research & Development | Immunosurpressive effects of pteridine derivatives |
| US6331547B1 (en) | 1999-08-18 | 2001-12-18 | American Home Products Corporation | Water soluble SDZ RAD esters |
| JP2003509425A (ja) | 1999-09-15 | 2003-03-11 | ワーナー−ランバート・カンパニー | キナーゼ阻害剤としてのプテリジノン |
| DE19944767A1 (de) | 1999-09-17 | 2001-03-29 | Vasopharm Biotech Gmbh & Co Kg | N-substituierte 4-Aminopteridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| US6440991B1 (en) | 2000-10-02 | 2002-08-27 | Wyeth | Ethers of 7-desmethlrapamycin |
| SE0003828D0 (sv) | 2000-10-20 | 2000-10-20 | Astrazeneca Ab | Novel compounds |
| DE10059864A1 (de) | 2000-11-30 | 2002-06-13 | Gruenenthal Gmbh | Substituierte Amino-furan-2-yl-essigsäure- und Amino-thien-2-yl-essigsäure-Derivate |
| EP2048142A3 (en) | 2001-04-26 | 2009-04-22 | Eisai R&D Management Co., Ltd. | Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
| EE200400042A (et) | 2001-06-28 | 2004-10-15 | Essential Therapeutics, Inc. | 8/17 heterotsüklilised ühendid ning nende kasutamine D-alanüül-D-alaniini ligaasi inhibiitoritena |
| US7344702B2 (en) | 2004-02-13 | 2008-03-18 | Bristol-Myers Squibb Pharma Company | Contrast agents for myocardial perfusion imaging |
| CA2463563A1 (en) | 2001-10-12 | 2003-04-17 | Irm Llc | Kinase inhibitor scaffolds and methods for their preparation |
| DE10202468A1 (de) | 2002-01-23 | 2004-09-30 | Faustus Forschungs Cie. Translational Cancer Research Gmbh | Pteridinderivate, Verfahren zu deren Herstellung und ihre Verwendung |
| AU2003229305A1 (en) | 2002-05-17 | 2003-12-02 | Scios, Inc. | TREATMENT OF FIBROPROLIFERATIVE DISORDERS USING TGF-Beta INHIBITORS |
| JP2006502236A (ja) | 2002-09-18 | 2006-01-19 | ファイザー・プロダクツ・インク | 形質転換成長因子(tgf)阻害剤としてのトリアゾール誘導体 |
| US20050282814A1 (en) | 2002-10-03 | 2005-12-22 | Targegen, Inc. | Vasculostatic agents and methods of use thereof |
| MXPA05003477A (es) | 2002-10-03 | 2005-07-22 | Targegen Inc | Agentes vasculo-estaticos y metodos de uso de los mismos. |
| US7262200B2 (en) | 2002-10-25 | 2007-08-28 | Vertex Pharmaceuticals Incorporated | Indazolinone compositions useful as kinase inhibitors |
| WO2004065392A1 (en) | 2003-01-24 | 2004-08-05 | Smithkline Beecham Corporation | Condensed pyridines and pyrimidines and their use as alk-5 receptor ligands |
| CL2004000234A1 (es) | 2003-02-12 | 2005-04-15 | Biogen Idec Inc | Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid |
| US7378409B2 (en) | 2003-08-21 | 2008-05-27 | Bristol-Myers Squibb Company | Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity |
| EP1658081B1 (en) | 2003-08-29 | 2007-10-24 | 4 Aza Ip Nv | Immunosuppressive effects of pteridine derivatives |
| GB2405793A (en) | 2003-09-12 | 2005-03-16 | 4 Aza Bioscience Nv | Pteridine derivatives for treating TNF-alpha related disorders |
| PL1663244T3 (pl) | 2003-09-12 | 2008-01-31 | 4 Aza Ip Nv | Pochodne pterydyny do leczenia chorób związanych z TNF-alfa |
| PE20050952A1 (es) | 2003-09-24 | 2005-12-19 | Novartis Ag | Derivados de isoquinolina como inhibidores de b-raf |
| PT1673092E (pt) | 2003-10-17 | 2007-11-23 | 4 Aza Ip Nv | ''derivados de pteridina substituídos com heterociclos e sua utilização em terapia'' |
| CA2545340A1 (en) | 2003-11-10 | 2005-05-26 | Synta Pharmaceuticals, Corp. | Fused heterocyclic compounds |
| US7541360B2 (en) | 2003-12-30 | 2009-06-02 | Vasopharm Gmbh | 4-amino-7,8-dihydropteridines, pharmaceutical compositions containing them and their use for the treatment of diseases which are caused by an increased nitric oxide level |
| EA012262B1 (ru) | 2004-01-22 | 2009-08-28 | Эли Лилли Энд Компани | Селективные модуляторы рецепторов эстрогена для лечения вазомоторных симптомов |
| TW200538120A (en) | 2004-02-20 | 2005-12-01 | Kirin Brewery | Compound having TGF-beta inhibitory activity and pharmaceutical composition containing same |
| EP1748991A1 (en) | 2004-04-28 | 2007-02-07 | Arrow Therapeutics Limited | Morpholinylanilinoquinazo- line derivatives for use as antiviral agents |
| CN1583747A (zh) | 2004-05-26 | 2005-02-23 | 中国药科大学 | 蝶呤类一氧化氮合酶抑制剂 |
| GB0417905D0 (en) | 2004-08-11 | 2004-09-15 | Novartis Ag | Organic compounds |
| US20070054916A1 (en) | 2004-10-01 | 2007-03-08 | Amgen Inc. | Aryl nitrogen-containing bicyclic compounds and methods of use |
| KR100915481B1 (ko) | 2004-11-09 | 2009-09-03 | 에프. 호프만-라 로슈 아게 | 아미노퀴나졸린 화합물 |
| DE102004057645A1 (de) | 2004-11-29 | 2006-06-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen |
| DE102004057595A1 (de) | 2004-11-29 | 2006-06-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen |
| GB0428475D0 (en) | 2004-12-30 | 2005-02-02 | 4 Aza Bioscience Nv | Pyrido(3,2-D)pyrimidine derivatives and pharmaceutical compositions useful as medicines for the treatment of autoimmune disorders |
| US20090264415A2 (en) | 2004-12-30 | 2009-10-22 | Steven De Jonghe | Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment |
| GB0503506D0 (en) | 2005-02-21 | 2005-03-30 | 4 Aza Bioscience Nv | Substituted pyrido(2,3-d) pyrimidine derivatives and pharmaceutical compositions useful as medicines for the treatment of autoimmune disorders |
| AR056347A1 (es) | 2005-05-12 | 2007-10-03 | Tibotec Pharm Ltd | Uso de compuestos de pteridina para fabricar medicamentos y composiciones farmaceuticas |
| WO2006135993A1 (en) | 2005-06-24 | 2006-12-28 | Gilead Sciences, Inc. | Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for treating hepatitis c. |
| TW201402124A (zh) | 2005-08-19 | 2014-01-16 | Array Biopharma Inc | 作為類鐸受體(toll-like receptor)調節劑之8-經取代苯并氮雜呯 |
| AU2007216247A1 (en) | 2006-02-17 | 2007-08-23 | Pfizer Limited | 3 -deazapurine derivatives as TLR7 modulators |
| WO2007135026A2 (de) | 2006-05-24 | 2007-11-29 | Boehringer Ingelheim International Gmbh | Substituierte pteridine als therapeutika |
| WO2007135027A1 (de) | 2006-05-24 | 2007-11-29 | Boehringer Ingelheim International Gmbh | Substituierte pteridine, die mit einem viergliedrigen heterocyclus substituiert sind |
| EP1870400A1 (en) | 2006-06-08 | 2007-12-26 | Boehringer Ingelheim Pharma GmbH & Co. KG | Salts and crystalline salt forms of an 2-indolinone derivative |
| US20090318456A1 (en) | 2006-07-06 | 2009-12-24 | Gilead Sciences, Inc. | Substituted pteridines for the treatment and prevention of viral infections |
| WO2008009078A2 (en) | 2006-07-20 | 2008-01-24 | Gilead Sciences, Inc. | 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections |
| US8673929B2 (en) | 2006-07-20 | 2014-03-18 | Gilead Sciences, Inc. | 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections |
| US8338435B2 (en) | 2006-07-20 | 2012-12-25 | Gilead Sciences, Inc. | Substituted pyrido(3,2-D) pyrimidines and pharmaceutical compositions for treating viral infections |
| DE102006033718B4 (de) | 2006-07-20 | 2017-10-19 | Siemens Aktiengesellschaft | Elektrische Maschine mit schräg verlaufenden Magnetpolgrenzen |
| WO2008009079A2 (en) | 2006-07-20 | 2008-01-24 | Gilead Sciences, Inc. | Substituted pteridines useful for the treatment and prevention of viral infections |
| JP2010501593A (ja) | 2006-08-24 | 2010-01-21 | セレネックス, インコーポレイテッド | イソキノリン、キナゾリンおよびフタラジン誘導体 |
| US8027888B2 (en) | 2006-08-31 | 2011-09-27 | Experian Interactive Innovation Center, Llc | Online credit card prescreen systems and methods |
| US8143394B2 (en) | 2006-12-26 | 2012-03-27 | Gilead Sciences, Inc. | Pyrido(3,2-d)pyrimidines useful for treating viral infections |
| WO2008077650A1 (en) | 2006-12-26 | 2008-07-03 | Gilead Sciences, Inc. | Pyrido(3,2-d)pyrimidines useful for treating viral infections |
| TW200840584A (en) | 2006-12-26 | 2008-10-16 | Gilead Sciences Inc | Pyrido(3,2-d)pyrimidines useful for treating viral infections |
| US7928111B2 (en) | 2007-06-08 | 2011-04-19 | Senomyx, Inc. | Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors |
| US9603848B2 (en) | 2007-06-08 | 2017-03-28 | Senomyx, Inc. | Modulation of chemosensory receptors and ligands associated therewith |
| US8633186B2 (en) | 2007-06-08 | 2014-01-21 | Senomyx Inc. | Modulation of chemosensory receptors and ligands associated therewith |
| JP2011506315A (ja) | 2007-12-05 | 2011-03-03 | バイアル−ポルテラ アンド シーエー,エス.エー. | 新たな塩、及び結晶形 |
| WO2010002998A1 (en) | 2008-07-03 | 2010-01-07 | Gilead Sciences, Inc. | 2,4,6-TRISUBSTITUTED PYRIDO (3,2-d) PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS |
| EP2313102A2 (en) | 2008-07-03 | 2011-04-27 | Biota Scientific Management | Bycyclic nucleosides and nucleotides as therapeutic agents |
| CA2732437C (en) | 2008-08-01 | 2017-11-21 | Ventirx Pharmaceuticals, Inc. | Toll-like receptor agonist formulations and their use |
| WO2010042489A2 (en) | 2008-10-06 | 2010-04-15 | Emory University | Aminoquinoline derived heat shock protein 90 inhibitors, methods of preparing same, and methods for their use |
| GB0819593D0 (en) | 2008-10-24 | 2008-12-03 | Ucb Pharma Sa | Therapeutic agents |
| UY32306A (es) | 2008-12-09 | 2010-07-30 | Gilead Sciences Inc | Derivados de pteridinona y pirimidinodiazepinona y composiciones farmacéuticas que modulan en forma selectiva los receptores tipo toll, métodos y usos |
| US8513284B2 (en) | 2009-02-13 | 2013-08-20 | Ucb Pharma, S.A. | Fused pyridine and pyrazine derivatives as kinase inhibitors |
| BR112012009329A2 (pt) | 2009-10-22 | 2016-06-07 | Gilead Sciences Inc | derivados de purina ou deazapurina úteis para o tratamento de infecções virais (inter alia) |
| WO2011057148A1 (en) | 2009-11-05 | 2011-05-12 | Irm Llc | Compounds and compositions as tlr-7 activity modulators |
| JP5848712B2 (ja) | 2009-12-11 | 2016-01-27 | ノノ インコーポレイテッド | 虚血性疾患および他の疾患を治療するための薬剤および方法 |
| WO2011097607A1 (en) | 2010-02-08 | 2011-08-11 | Southern Research Institute | Anti-viral treatment and assay to screen for anti-viral agent |
| FR2959510B1 (fr) | 2010-04-28 | 2013-04-26 | Centre Nat Rech Scient | Derives de pyrido[3,2-d]pyrimidine, leurs procedes de preparation et leurs utilisations therapeutiques |
| WO2012058601A1 (en) | 2010-10-28 | 2012-05-03 | Southern Research Institute | Small molecule inhibitors of bacterial motility and a high throughput screening assay for their identification |
| WO2012064973A2 (en) | 2010-11-10 | 2012-05-18 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| US8664230B2 (en) | 2011-03-17 | 2014-03-04 | The Asan Foundation | Pyridopyrimidine derivatives and use thereof |
| ES2691745T3 (es) | 2011-04-08 | 2018-11-28 | Janssen Sciences Ireland Uc | Derivados de pirimidina para el tratamiento de infecciones víricas |
| PL2709989T3 (pl) | 2011-05-18 | 2018-06-29 | Janssen Sciences Ireland Uc | Pochodne chinazoliny do leczenia infekcji wirusowych i dalszych chorób |
| EP2734520B1 (en) | 2011-07-19 | 2016-09-14 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| WO2013060881A1 (en) | 2011-10-27 | 2013-05-02 | Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg | Pyridopyrimidines and their therapeutic use |
| WO2013090840A1 (en) | 2011-12-15 | 2013-06-20 | Gilead Sciences, Inc. | 2 -amino- pyrido [3, 2 -d] pyrimidine derivatives as hcv inhibitors |
| EA039373B1 (ru) | 2012-02-08 | 2022-01-19 | Янссен Сайенсиз Айрлэнд Юси | Производные пиперидино-пиримидина для лечения вирусных инфекций |
| CA2873984A1 (en) | 2012-05-23 | 2013-11-28 | Stemergie Biotechnology Sa | Inhibitors of the activity of complex (iii) of the mitochondrial electron transport chain and use thereof |
| JP6302906B2 (ja) | 2012-08-10 | 2018-03-28 | ヤンセン・サイエンシズ・アイルランド・ユーシー | ウイルス感染および他の疾患を治療するためのアルキルピリミジン誘導体 |
| MX386924B (es) | 2012-10-10 | 2025-03-19 | Janssen Sciences Ireland Uc | Derivados pirrolo[3,2-d]pirimidínicos para el tratamiento de infecciones víricas y otras enfermedades. |
| MX2015005949A (es) | 2012-11-16 | 2015-09-08 | Biocryst Pharm Inc | Nucleosidos que contienen aza-azucar antiviral. |
| US9663474B2 (en) | 2012-11-16 | 2017-05-30 | Janssen Sciences Ireland Uc | Heterocyclic substituted 2-amino quinazoline derivatives for the treatment of viral infections |
| US9283242B2 (en) | 2013-01-22 | 2016-03-15 | Massachusetts Institute Of Technology | Uses of dihydro bases |
| BR122021012629B1 (pt) | 2013-02-01 | 2022-06-07 | Wellstat Therapeutics Corporation | Compostos de amina, composição compreendendo os referidos compostos e usos dos mesmos |
| KR102300861B1 (ko) | 2013-02-21 | 2021-09-10 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | 바이러스 감염의 치료를 위한 2-아미노피리미딘 유도체 |
| ES2836881T3 (es) | 2013-07-30 | 2021-06-28 | Janssen Sciences Ireland Unlimited Co | Derivados de tieno[3,2-d]pirimidinas para el tratamiento de infecciones virales |
| EP3054944B1 (en) | 2013-10-07 | 2019-12-04 | Merck Sharp & Dohme Corp. | Factor xia inhibitors |
| WO2015168269A1 (en) | 2014-05-01 | 2015-11-05 | Novartis Ag | Compounds and compositions as toll-like receptor 7 agonists |
| MX2016016516A (es) | 2014-06-13 | 2017-05-01 | Gilead Sciences Inc | Inhibidores de fosfatidilinositol 3-cinasa. |
| CN110305133A (zh) | 2014-09-16 | 2019-10-08 | 吉利德科学公司 | Toll样受体调节剂的固体形式 |
| SG11201606876RA (en) | 2015-03-04 | 2016-10-28 | Gilead Sciences Inc | Toll like receptor modulator compounds |
| US20180263985A1 (en) | 2015-09-15 | 2018-09-20 | Gilead Sciences, Inc. | Modulators of toll-like receptors for the treatment of hiv |
| MA45539A (fr) | 2016-07-01 | 2019-05-08 | Janssen Sciences Ireland Unlimited Co | Dihydropyranopyrimidines pour le traitement d'infections virales |
| WO2018045150A1 (en) | 2016-09-02 | 2018-03-08 | Gilead Sciences, Inc. | 4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators |
| SI3507276T1 (sl) | 2016-09-02 | 2022-01-31 | Gilead Sciences, Inc. | Spojine modulatorja toličnih receptorjev |
| EP3618829B1 (en) | 2017-05-05 | 2023-06-07 | Arcus Biosciences, Inc. | Quinazoline-pyridine derivatives for the treatment of cancer-related disorders |
| FI3641771T3 (fi) | 2017-06-23 | 2026-08-11 | Birdie Biopharmaceuticals Inc | Farmaseuttisia koostumuksia |
| TWI751517B (zh) | 2019-04-17 | 2022-01-01 | 美商基利科學股份有限公司 | 類鐸受體調節劑之固體形式 |
| TW202210480A (zh) | 2019-04-17 | 2022-03-16 | 美商基利科學股份有限公司 | 類鐸受體調節劑之固體形式 |
| WO2020255038A1 (en) | 2019-06-18 | 2020-12-24 | Janssen Sciences Ireland Unlimited Company | Combination of hepatitis b virus (hbv) vaccines and pyridopyrimidine derivatives |
| TWI879779B (zh) | 2019-06-28 | 2025-04-11 | 美商基利科學股份有限公司 | 類鐸受體調節劑化合物的製備方法 |
| US20240269142A1 (en) | 2021-05-13 | 2024-08-15 | Gilead Sciences, Inc. | COMBINATION OF A TLR8 MODULATING COMPOUND AND ANTI-HBV siRNA THERAPEUTICS |
-
2020
- 2020-06-24 TW TW109121724A patent/TWI879779B/zh active
- 2020-06-25 JP JP2021577420A patent/JP7246526B2/ja active Active
- 2020-06-25 CA CA3144953A patent/CA3144953C/en active Active
- 2020-06-25 EP EP20740149.8A patent/EP3990455A1/en active Pending
- 2020-06-25 CN CN202080057308.3A patent/CN114269744B/zh active Active
- 2020-06-25 CN CN202411379617.9A patent/CN119371422A/zh active Pending
- 2020-06-25 AU AU2020304069A patent/AU2020304069C1/en active Active
- 2020-06-25 KR KR1020227002741A patent/KR102670017B1/ko active Active
- 2020-06-25 WO PCT/US2020/039501 patent/WO2020264081A1/en not_active Ceased
- 2020-06-25 US US16/911,643 patent/US11286257B2/en active Active
- 2020-06-25 KR KR1020247017239A patent/KR102928687B1/ko active Active
- 2020-06-25 CA CA3248411A patent/CA3248411A1/en active Pending
-
2022
- 2022-02-16 US US17/673,141 patent/US12590089B2/en active Active
-
2023
- 2023-03-14 JP JP2023039821A patent/JP7626788B2/ja active Active
-
2024
- 2024-03-20 AU AU2024201832A patent/AU2024201832A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN119371422A (zh) | 2025-01-28 |
| WO2020264081A1 (en) | 2020-12-30 |
| AU2020304069C1 (en) | 2025-02-13 |
| JP2022538298A (ja) | 2022-09-01 |
| KR102670017B1 (ko) | 2024-05-29 |
| EP3990455A1 (en) | 2022-05-04 |
| KR20240090883A (ko) | 2024-06-21 |
| CA3248411A1 (en) | 2025-07-09 |
| JP7626788B2 (ja) | 2025-02-04 |
| CN114269744B (zh) | 2024-10-18 |
| US12590089B2 (en) | 2026-03-31 |
| AU2020304069A1 (en) | 2022-02-17 |
| TWI879779B (zh) | 2025-04-11 |
| KR102928687B1 (ko) | 2026-02-20 |
| US11286257B2 (en) | 2022-03-29 |
| US20220274985A1 (en) | 2022-09-01 |
| CN114269744A (zh) | 2022-04-01 |
| TW202115056A (zh) | 2021-04-16 |
| AU2024201832A1 (en) | 2024-04-11 |
| US20210017170A1 (en) | 2021-01-21 |
| AU2020304069B2 (en) | 2023-12-21 |
| CA3144953A1 (en) | 2020-12-30 |
| JP2023073288A (ja) | 2023-05-25 |
| KR20220038357A (ko) | 2022-03-28 |
| JP7246526B2 (ja) | 2023-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2020304069B2 (en) | Processes for preparing Toll-like receptor modulator compounds | |
| JP7106462B2 (ja) | N-(ヘテロアリール)-ピロロ[3,2-d]ピリミジン-2-アミンの合成 | |
| CA2621640C (en) | Optically active diamine derivative and process for producing the same | |
| WO2010126820A2 (en) | Preparation of alkyl esters of n-protected oxo-azacycloalkylcarboxylic acids | |
| KR20190034231A (ko) | 신규 화합물 및 이의 제조방법 | |
| HK40067766A (en) | Processes for preparing toll-like receptor modulator compounds | |
| Montana et al. | Rapid Synthesis of New Azaheterocyclic Hydroxymaionate Derivatives Using TDAE Approach | |
| HK40115601A (en) | Processes for preparing toll-like receptor modulator compounds | |
| HK40067766B (en) | Processes for preparing toll-like receptor modulator compounds | |
| Vypolzov et al. | Synthesis of cinnoline 1-oxides by the reaction of ortho-fluoronitrobenzenes with enediamines | |
| JPH0481583B2 (cg-RX-API-DMAC10.html) | ||
| CA3147838C (en) | Method for preparing l-erythrobiopterin compound | |
| Adapted from Steiniger et al. | 4.1 Divergent Reactivity of Diazene Denitrogenation | |
| JP2025138461A (ja) | ウレア化合物の製造方法 | |
| WO2024219292A1 (ja) | 飽和脂肪族アミンの製造方法、及びカルボン酸の還元的アミノ化触媒 | |
| WO2025005098A1 (ja) | イソシアネートの製造方法 | |
| Duddu. S et al. | Visible-Light-Induced Oxidative Cleavage of CC Triple Bond via Hydroamination: Direct Synthesis of Oxamates from Amines and Activated Alkynes | |
| Kobayashi et al. | Two‐Step Synthesis of 1, 3‐Disubstituted 3, 4‐Dihydro‐4‐thioxoquinazolin‐2 (1H)‐ones from 1‐Bromo‐2‐fluorobenzenes | |
| Kelleher et al. | Use of the Mitsunobu Reaction in the Synthesis of Orthogonally Protected a, b-Diaminopropionic Acids | |
| RK Murthia et al. | Revisiting Iodine-mediated N-tert-Butoxycarbonylation of Amines | |
| HK40002783A (en) | New compound and process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20211222 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D00-D164 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: RESPONSE TO NOTICE OF ALLOWANCE Effective date: 20240712 |
|
| B12 | Application deemed to be withdrawn, abandoned or lapsed |
Free format text: ST27 STATUS EVENT CODE: N-4-6-B10-B12-B302 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - CONDITIONS FOR GRANT DETERMINED NOT COMPLIANT Effective date: 20240715 |
|
| B12 | Application deemed to be withdrawn, abandoned or lapsed |
Free format text: ST27 STATUS EVENT CODE: N-2-6-B10-B12-B302 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - CONDITIONS FOR GRANT DETERMINED NOT COMPLIANT Effective date: 20240909 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD Year of fee payment: 5 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20241224 |
|
| D22 | Grant of ip right intended |
Free format text: ST27 STATUS EVENT CODE: A-2-4-D10-D22-D143 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: PRE-GRANT Effective date: 20250716 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250716 |
|
| D22 | Grant of ip right intended |
Free format text: ST27 STATUS EVENT CODE: A-2-4-D10-D22-D143 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: PRE-GRANT Effective date: 20251016 |
|
| Q17 | Modified document published |
Free format text: ST27 STATUS EVENT CODE: A-4-4-Q10-Q17-Q103 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DOCUMENT PUBLISHED Effective date: 20251105 |
|
| F11 | Ip right granted following substantive examination |
Free format text: ST27 STATUS EVENT CODE: A-4-4-F10-F11-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: GRANT BY ISSUANCE Effective date: 20251118 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260106 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 6TH ANNIV.) - STANDARD Year of fee payment: 6 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260401 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260401 |